IMbrave150 study by Roche shows promise for combination immunotherapy for liver cancer patients. Having first begun in 2018, the IMbrave150 study aimed to study the combination therapy of...
The War against Nasopharyngeal Carcinoma. by Dr Melvin L.K. Chua Nasopharyngeal carcinoma (NPC) is a unique cancer of the head and neck region that is prevalent in Southern and South-eastern Asia....
The result of a collaborative effort between scientists from the National Cancer Centre Singapore (NCCS) and Sun Yat-sen University Cancer Centre (SYSUCC). The artificial intelligence (AI) tool aims...
New method expected to be more convenient and non-invasive to identify early stage liver cancer. Chinese scientists have designed a new screening method for hepatitis B carriers, to detect...
